Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C015001 |
arsenite |
[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of PDSS1 mRNA | affects cotreatment|decreases expression | 15894712
|
C015001 |
arsenite |
arsenite results in decreased expression of PDSS1 mRNA | decreases expression | 15894712
|
D001564 |
Benzo(a)pyrene |
[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of PDSS1 mRNA | affects cotreatment|decreases expression | 15894712
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of PDSS1 mRNA | decreases expression | 15894712
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PDSS1 mRNA | decreases expression | 20382639
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of PDSS1 mRNA | decreases expression | 20106945
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PDSS1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PDSS1 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of PDSS1 mRNA | increases expression | 18301758 17950772
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of PDSS1 mRNA] | increases expression|increases reaction | 17950772
|
D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of PDSS1 mRNA | decreases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.95 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.25 | 19490988 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.04 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.82 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.94 | 16434500 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.75 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.83 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.49 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18396377 18316065 19232924 18177632 17688650 17507914 18775368 18558336 16609825 20603192 18940202 15238991 17157402 18985861 19460635 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.21 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.47 | 19483382 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.59 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.00 | 20146248 17474063 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.12 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.26 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.26 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.80 | 20734317 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.53 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.53 | 19176532 |
OMIM:607426 |
COENZYME Q10 DEFICIENCY |
marker/mechanism |
|
| |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.62 | 15037631 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 16575769 8888407 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.24 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.40 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.80 | 12083418 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.57 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.44 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.07 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.87 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.71 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.53 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.57 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.57 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
21.66 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
21.66 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
21.66 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
21.66 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.41 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.51 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
arsenite |
10.32 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
10.32 | 12168785 12639820 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.68 | 8708960 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.80 | 20471113 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.88 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.41 | 19176532 18467677 16221962 19772884 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.33 | 17688650 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.19 | 10903974 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.82 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.96 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.50 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.00 | 12371664 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 17596541 16294345 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.57 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.70 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.70 | 20007298 15890375 16377806 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.78 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
2.67 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.67 | 18816296 20135361 18569708 6695378 20064080 18520028 20869020 17053015 20464547 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.31 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.41 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.43 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.35 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.31 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.19 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.28 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.28 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.87 | 15738583 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.96 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.57 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.32 | 8888407 16359493 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.87 | 20558911 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.51 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.29 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.92 | 17292933 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.06 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.31 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.53 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.94 | 3137016 1511512 14763951 11044598 16876388 11738929 17978042 15475178 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.49 | 19755658 10029692 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.02 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.06 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.75 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.98 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.28 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.06 | 8888407 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.50 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.96 | 17120751 |